Gerhard Koenig

1.2k total citations
29 papers, 878 citations indexed

About

Gerhard Koenig is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Gerhard Koenig has authored 29 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Physiology. Recurrent topics in Gerhard Koenig's work include Cholinesterase and Neurodegenerative Diseases (12 papers), Alzheimer's disease research and treatments (10 papers) and Nicotinic Acetylcholine Receptors Study (9 papers). Gerhard Koenig is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (12 papers), Alzheimer's disease research and treatments (10 papers) and Nicotinic Acetylcholine Receptors Study (9 papers). Gerhard Koenig collaborates with scholars based in United States, Netherlands and Germany. Gerhard Koenig's co-authors include F. Josef van der Staay, Christina Erb, Martin Hendrix, Frank Boess, Jos Prickaerts, Rudy Schreiber, Arjan Blokland, Jan de Vente, Dana Hilt and Maria S. Gawryl and has published in prestigious journals such as Journal of Neurophysiology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gerhard Koenig

27 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Koenig United States 12 583 310 296 167 89 29 878
Cornelia Dorner‐Ciossek Germany 19 412 0.7× 220 0.7× 205 0.7× 176 1.1× 109 1.2× 41 817
Philippe Pichat France 16 448 0.8× 424 1.4× 206 0.7× 159 1.0× 125 1.4× 26 981
Holger Rosenbrock Germany 23 525 0.9× 512 1.7× 264 0.9× 184 1.1× 206 2.3× 62 1.2k
Jesper F. Bastlund Denmark 22 496 0.9× 491 1.6× 185 0.6× 135 0.8× 300 3.4× 55 1.2k
Ayhan Şık Netherlands 10 585 1.0× 445 1.4× 341 1.2× 143 0.9× 238 2.7× 10 1.1k
Eva Bollen Netherlands 12 589 1.0× 226 0.7× 358 1.2× 145 0.9× 100 1.1× 14 884
Nathan L. Absalom Australia 20 740 1.3× 555 1.8× 220 0.7× 67 0.4× 72 0.8× 41 1.2k
Karla Drescher Germany 17 488 0.8× 607 2.0× 166 0.6× 77 0.5× 149 1.7× 31 1.0k
Martina Kaniaková Czechia 15 449 0.8× 476 1.5× 269 0.9× 115 0.7× 60 0.7× 26 897
Olivier Bergis France 14 408 0.7× 432 1.4× 185 0.6× 78 0.5× 137 1.5× 19 788

Countries citing papers authored by Gerhard Koenig

Since Specialization
Citations

This map shows the geographic impact of Gerhard Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Koenig more than expected).

Fields of papers citing papers by Gerhard Koenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Koenig. The network helps show where Gerhard Koenig may publish in the future.

Co-authorship network of co-authors of Gerhard Koenig

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Koenig. A scholar is included among the top collaborators of Gerhard Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Koenig. Gerhard Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xiaowen, Christopher J. Holler, Angelo Pugliese, et al.. (2023). Discovery and characterization of novel TRPML1 agonists. Bioorganic & Medicinal Chemistry Letters. 98. 129595–129595. 3 indexed citations
2.
Hurst, Raymond S, Jean‐François Blain, Christopher J. Holler, et al.. (2023). ARKD‐104, A Potential Treatment of Frontotemporal Dementia and Other Neurodegenerative Disorders. Alzheimer s & Dementia. 19(S21). 1 indexed citations
3.
Peng, Xiaowen, James C. Lanter, Wim Zonneveld, et al.. (2022). Discovery of oxazoline enhancers of cellular progranulin release. Bioorganic & Medicinal Chemistry Letters. 80. 129048–129048. 2 indexed citations
4.
Blain, Jean‐François, James C. Lanter, Christopher J. Holler, et al.. (2022). A Novel In Vivo‐Active Small Molecule Inducer of Progranulin for the Treatment of Frontotemporal Dementia. Alzheimer s & Dementia. 18(S10). 1 indexed citations
5.
Lanter, James C., et al.. (2021). Discovery of quinuclidine modulators of cellular progranulin. Bioorganic & Medicinal Chemistry Letters. 47. 128209–128209. 3 indexed citations
6.
Blume, Tanja, Severin Filser, Anna Jaworska, et al.. (2018). BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines. Frontiers in Aging Neuroscience. 10. 229–229. 30 indexed citations
7.
Masilamoni, Gunasingh, et al.. (2016). Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile. Neuropharmacology. 110(Pt A). 449–457. 6 indexed citations
8.
Blain, Jean‐François, Matthew G. Bursavich, Lori Hrdlicka, et al.. (2016). Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease. Alzheimer s Research & Therapy. 8(1). 34–34. 16 indexed citations
9.
Stoiljković, Milan, et al.. (2016). Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β overproducing transgenic mice. Neurobiology of Aging. 45. 161–168. 22 indexed citations
10.
Jin, Hong, Ting Chen, Dooyoung Lee, et al.. (2016). Intracellular Retention of Three Quinuclidine Derivatives in Caco-2 Permeation Experiments: Mechanisms and Impact on Estimating Permeability and Active Efflux Ratio. Drug Metabolism Letters. 10(3). 161–171. 2 indexed citations
11.
Goethem, Nick P. van, Jos Prickaerts, Devin Welty, Dorothy G. Flood, & Gerhard Koenig. (2015). Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats. Behavioural Pharmacology. 26(4). 403–406. 10 indexed citations
12.
Stoiljković, Milan, Liza Leventhal, Angela Chen, et al.. (2015). Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Biochemical Pharmacology. 97(4). 576–589. 24 indexed citations
13.
Keefe, Richard S.E., Nancy Dgetluck, Maria S. Gawryl, et al.. (2015). Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. Neuropsychopharmacology. 40(13). 3053–3060. 120 indexed citations
14.
Tang, Cuyue, Ting Chen, Tao Yi, et al.. (2014). Neuropharmacokinetics of two investigational compounds in rats: Divergent temporal profiles in the brain and cerebrospinal fluid. Biochemical Pharmacology. 91(4). 543–551. 11 indexed citations
15.
Wu, Jun, V. A. Vigont, Lori Hrdlicka, et al.. (2011). Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment. Chemistry & Biology. 18(6). 777–793. 127 indexed citations
16.
Felsenstein, Kevin M., Zhiyong Yang, Scott Nolan, et al.. (2010). P3‐295: Pharmacokinetic and pharmacodynamic analysis of the gamma‐secretase modulator (GSM) EVP‐0015962. Alzheimer s & Dementia. 6(4S_Part_17). 4 indexed citations
17.
18.
Boess, Frank, Jean De Vry, Christina Erb, et al.. (2007). The Novel α7 Nicotinic Acetylcholine Receptor Agonist N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents. Journal of Pharmacology and Experimental Therapeutics. 321(2). 716–725. 125 indexed citations
19.
Boess, Frank, Martin Hendrix, F. Josef van der Staay, et al.. (2004). Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology. 47(7). 1081–1092. 251 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelia Dorner‐Ciossek Breakdown of academic impact, for papers by Philippe Pichat Breakdown of academic impact, for papers by Holger Rosenbrock Breakdown of academic impact, for papers by Jesper F. Bastlund Breakdown of academic impact, for papers by Ayhan Şık Breakdown of academic impact, for papers by Eva Bollen Breakdown of academic impact, for papers by Nathan L. Absalom Breakdown of academic impact, for papers by Karla Drescher Breakdown of academic impact, for papers by Martina Kaniaková Breakdown of academic impact, for papers by Olivier Bergis
Rankless by CCL
2026